Akers Biosciences Inc (NASDAQ:AKER)

Delayed Data
As of Aug 14
 +0.63 / +11.54%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Akers Biosciences Inc have a median target of 768.00, with a high estimate of 768.00 and a low estimate of 768.00. The median estimate represents a +12,510.84% increase from the last price of 6.09.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Akers Biosciences Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 122.95%


Growthquarterly --
Growthannually 179.93%
Key to the earnings and sales forecast charts.